Duzel et al., Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights, World J
Long-Term Safety and Toxicity Animal studies have not consistently shown major toxicity signals, which is one reason interest in BPC 157 has continued
Xenical was followed by the lower dose, over-the-counter (OTC) orlistat (alli) in 2007
Modern peptide synthesis is dominated by solid-phase peptide synthesis (SPPS), which allows for the creation of a highly pure synthetic peptide, pioneered by Bruce Merrifield and refined over decades
Patients who are pregnant or breastfeeding, patients with active malignancy, patients with certain vascular conditions where angiogenesis is a concern, and patients on specific anticoagulants may not be candidates